Table 3 Adverse outcomes
TIVA | INHA | P Value | |
N (%) | N (%) | ||
Dichotomous Outcomes | |||
30-day Mortality | 4 (2.1) | 11 (4.7) | 0.106 |
MACE | 4 (2.1) | 11 (4.7) | 0.106 |
MOD | 6 (3.3) | 9 (3.9) | 0.797 |
Blood Transfusion | 80 (43.5) | 78 (33.5) | 0.189 |
Median (IQR) | Median (IQR) | ||
Continuous Outcomes | |||
Blood Loss | 400 (245,800) | 400 (300,800) | 0.301 |
Length of Stay (days) | 15 (13,20) | 16 (13,20) | 0.920 |